Chlamydia and Mycoplasma in Coronary Artery Disease

Prevalence of Chlamydia Pneumoniae and Mycoplasma Pneumoniae in Different Forms of Obstructive Coronary Artery Disease

To test the association between anti-Chlamydia serum titers and anti-Mycoplasma antibodies with Acute Coronary Syndromes.

One hundred and twenty-six patients were divided into 4 groups: Acute Coronary Syndrome with ST-elevation, Non-ST-elevation, stable coronary artery disease, and individuals without coronary disease. Anti-Chlamydia and anti-Mycoplasma IgG antibodies were measured at baseline and after 6 months.

Inclusion Criteria:

• Age >18 yrs
• Males and females
• Agreed to sign the informed consent

Exclusion Criteria:

• Refusal to sign the informed consent
• Follow-up not possible
• For the "acute" groups, time between the pain beginning and randomization >24 hours
• Active infections
• Use of antimicrobial agents within the last 30 days
• End-stage diseases with life expectancy <6 months